Medicare seeks public comments as the agency plans to list up to 15 additional drugs selected for the third round of pricing ...

The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in ...

President Trump’s executive order to lower drug prices through cross-agency action left pharma leaders scrambling to make ...

President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era ...

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...

A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ ...

CMS said on Monday that it would announce a list of 15 drugs eligible for a third round of Medicare price negotiations by early February next year. For the first time, the list would include drugs ...

CMS proposed several changes for the third round of Medicare drug price negotiations, including the potential inclusion of some drugs under Medicare Part B, in a draft guidance published May 12. The ...

President Donald Trump wants drugmakers to work with his federal health department to reach an agreement on a most favored ...

AARP also calls on Congress to protect and strengthen Medicare’s ability to negotiate lower drug prices for millions of older ...

The Legislature and Gov. Maura Healey last year enacted a pair of new health policy laws, including one aimed at reining in ...

The executive order would require other countries to pay more for medications so that Americans could pay less. But experts ...